2016 American Transplant Congress » Poster Session A: Kidney: Acute Cellular Rejection
Date: Saturday, June 11, 2016
Time: 5:30pm-7:30pm
Location: Halls C&D
Session Type: Poster Session
Meeting: 2016 American Transplant Congress
- 5:30pm-7:30pm
A Novel Quantitative CD45 Immunofluorescence Assay Can Measure Inflammatory Load in Renal Transplant Biopsies with Excellent Reproducibility and Repeatability.
Z. Laszik,1 D. Dobi,1 L. Laszik,1 D. Ikle,2 S. Chandran,1 F. Vincenti.1
- 5:30pm-7:30pm
A Quantitative CD45 Assay May Improve Diagnostic Accuracy of the Diagnosis of Acute Cellular Rejection in Transplant Kidney Biopsies.
L. Laszik, S. Bowman, V. Walavalkar, F. Vincenti, Z. Laszik.
- 5:30pm-7:30pm
A Quantitative CD45 Immunohistochemical Assay Allows Precise and Reproducible Measurement of Inflammation in Renal Transplant Biopsies.
V. Walavalkar,1 S. Bowman,1 L. Laszik,1 D. Ikle,2 S. Chandran,1 F. Vincenti,1 Z. Laszik.1
- 5:30pm-7:30pm
Acute Allograft Glomerulopathy: A Distinct Form of Cellular Rejection.
O. AL-Badri, M. Alexander, F. Cosio, L. Cornell.
- 5:30pm-7:30pm
Acute Rejection Profoundly Impacts Graft Survival in Young but Not in Old Kidney Transplant Recipients.
C. Denecke,1,3 M. Biebl,1,3 J. Fritz,2 A. Brandl,1,4 S. Weiss,1,4 T. Dziodzio,1,3 F. Aigner,1,3 R. Sucher,1,3 C. Bösmüller,1 J. Pratschke,1,3,4 R. Öllinger.1,3
- 5:30pm-7:30pm
Analysis of T Cell Receptor Repertoire in Routine Renal Allograft Biopsy.
R. Reindl-Schwaighofer,1 J. Weinberger,1 R. Jimenez-Heredia,1 J. Sunzenauer,1 S. Schaller,2 S. Winkler,2 R. Oberbauer.1
- 5:30pm-7:30pm
Biopsies for Delayed Graft Function After Alemtuzumab Induction in Kidney Transplantation: The Incidence of Early Rejection After Alemtuzumab Is Very Low but Not Negligible.
E. McGuire, C. Roufosse, T. Cook, D. Ashby, T. Cairns, J. Galliford, M. Willicombe, D. Taube, A. McLean.
- 5:30pm-7:30pm
Clinical Impact of Pre-Transplant Serum 25-Hydroxyvitamin D Levels on the Post-Transplant Immunologic and Non-Immunologic Outcomes in Kidney Transplant Recipients.
T. Ban,1,2 J. Kim,1,2 Y. Lee,1 B. Choi,1,2 C. Park,1,2 C. Yang,1,2 Y.-S. Kim,1,2 B. Chung.1,2
- 5:30pm-7:30pm
Clinical Outcome in Pure T-Cell Mediated Acute Rejection of the Kidney with No Donor Specific Antibody or C4d Staining.
P. Randhawa,1 G. Huang,2 S. Randhawa,1 G. Zeng,1 X. Zhao.3
- 5:30pm-7:30pm
Comparison of Efficacy and Safety of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus.
P. Gatault,1 N. Kamar,2 M. Buchler,1 C. Colosio,3 D. Bertrand,4 A. Durrbach,5 L. Albano,6 J. Rivalan,7 M. Essig,8 Y. Le Meur,9 N. Bouvier,10 B. Charpentier,5 E. Thervet,11 L. Rostaing,2 Y. Lebranchu.1
- 5:30pm-7:30pm
Comparison of Pharmacokinetic and Clinical Outcomes of Tacrolimus Hexal® with Prograf® Based Regimen in De Novo Kidney Transplant Recipients: Results from the Randomized, SparTacus Study.
W. Arns,1 A. Huppertz,1 T. Rath,1 S. Ziefle,1 L. Rump,1 A. Hansen,1 D. Baeumer,2 K. Budde,1 L. Lehner,1 T. Klein,1 P. Schenker.1
- 5:30pm-7:30pm
Continuous Antithymocyte Globulin (rATG) for Treatment of Renal Allograft Rejection: Preliminary Analysis of a Prospective, Randomized Trial.
S. Patel, R. Knight, S. Kuten, J. Nolte, A. Gaber.
- 5:30pm-7:30pm
Cytokine Networks in Kidney Transplant Patients.
R. Sabat,1 E. Witte,1 P. Reinke,2 K. Wolk,1 N. Babel.3,4
- 5:30pm-7:30pm
End Stage Renal Disease Patients Have a Skewed T Cell Receptor Vbeta Repertoire.
L. Huang,1 A. Langerak,2 I. Wolvers - Tettero,2 R. Meijers,1 C. Baan,1 N. Litjens,1 M. Betjes.1
- 5:30pm-7:30pm
Exposure Analysis for the Composite Efficacy Endpoints in the US92 Phase 3 Kidney Transplantation Trial to Understand Center Effects.
F. Shihab, B. Kaplan, K. McCague, D. Patel, F. Vincenti.
- 5:30pm-7:30pm
Higher Pre-Transplant Triglyceride Levels Are Associated with Increased Acute Cellular Rejection Risk Following Kidney Transplant.
J. Hagopian,1 D. Brennan,2 K. Lentine,3 T. Horwedel.1
- 5:30pm-7:30pm
Immunological Ageing-Related Expansion of Highly Differentiated CD4+CD28null T Cells Is Associated with a Lower Risk for Early Acute Rejection After Renal Transplantation.
B. Dedeoglu, R. Meijers, M. Klepper, D. Hesselink, C. Baan, N. Litjens, M. Betjes.
- 5:30pm-7:30pm
NanoString Detection of Gene Signatures in Urine During Acute Cellular Rejection of Kidney Grafts.
K. Keslar,1 A. Zmijewska,2 J. Andriga,2 K. Newell,3 R. Mannon,2 P. Heeger,4 R. Fairchild.1
- 5:30pm-7:30pm
Natural Language Processing Methods Allow Reliable Extraction of Banff Scores and Grades.
K. Reilly,1 L. Lenert,1 H. Anwar,2 J. Thompson,1 D. Taber,1 P. Mauldin,1 T. Srinivas.1
- 5:30pm-7:30pm
Plasma Endothelial Microvesicle Counts Indicate Allograft Rejection Following Kidney Transplantation.
D. Zecher,1 A. Cumpelik,2 B. Ruhland,1 B. Banas,1 H. Hopfer,3 M. Dickenmann,4 J. Schifferli.2
- 5:30pm-7:30pm
Post-Transplant Reduction of Long Lived Plasma Cells from Peripheral Circulation Is Associated with Acute Rejection in Kidney Transplant Recipients.
R. Minz,1 R. Dhital,2 M. Minz,2 R. Nada,3 A. Sharma,2 S. Singh,2 D. Kenwar.2
- 5:30pm-7:30pm
Pre-Formed AT1R Antibodies Are Associated with Rejection After Kidney Transplantation.
D. Kim, P. Warner, K. Nelson, I. Gimferrer, C. Johnson, C. Blosser, R. Bakthavatsalam, N. Leca.
- 5:30pm-7:30pm
Rapid Emergence of CD28null Cells Following Ex Vivo Restimulation Is Associated with Belatacept Resistant Rejection.
M. Cortes, S. Laurie, B. Sayed, M. Ford.
- 5:30pm-7:30pm
Recipient Age and KDPI Are Potent Predictors of Early Acute Rejection in the Modern Era of Deceased Donor Kidney Transplantation.
D. Keith, G. Vranic, A. Nishio Lucar.
- 5:30pm-7:30pm
Surveillance Biopsy Findings with Alemtuzumab (ALZ) Induction in Kidney Transplantation.
H. Madariaga,1 R. Ugarte,1 C. Drachenberg,2 N. Costa,1 B. Thomas,1 J. Bromberg,3 M. Weir,1 A. Haririan.1
- 5:30pm-7:30pm
The Impact of Allograft Rejection on DNA Methylation After Kidney Transplantation.
K. Boer, E. de Wit, D. Hesselink, L. Hofland, M. Betjes, C. Baan.
- 5:30pm-7:30pm
The Impact of Treating Borderline Cellular Rejections.
R. Mustafa,1 Y. Al Azzi,1 J. Crew,1 G. Dube,1 H. Morris,1 M. Chiles,1 J. Chang,1 H. Fernandez,1 D. Cohen,1 I. Batal,2 E. Campenot,2 S. Mohan.1
- 5:30pm-7:30pm
The Urine Common Rejection Module (uCRM) Is a Sentinal Assay for Graft Rejection.
T. Sigdel,1 T. Tran,1 O. Bestard,2 F. Vincenti,1 M. Sarwal.1
- 5:30pm-7:30pm
Transcriptome Profiles in Peripheral Blood of Kidney Graft Recipients.
J.-W. Seo,1 H. Moon,1 Y.-G. Kim,1 K.-H. Jeong,1 S.-J. Ihm,2 J.-Y. Moon,1 S.-H. Lee.1
- 5:30pm-7:30pm
Transitional B Cell T1/T2 Ratio Is a Prognostic Marker for Human Renal Allograft Deterioration.
A. Cherukuri,1 D. Rothstein,1 R. Baker.2
- 5:30pm-7:30pm
Urinary Exosomal Annexin A1 Is a Predictive Biomarker of Post Kidney Transplant Complications.
H. Harada,1 T. Murakami,2 C. Yamamoto,2 K. Hotta,1 N. Fukuzawa,1 M. Mitsuhashi.2
- 5:30pm-7:30pm
Urinary Expression of miRNA-155, miRNA-210, miRNA-142 and CXCL-10 Production Predicts the Risk of Acute Rejection and Graft Outcome in Renal Transplant Recipients.
O. Millan,1 K. Budde,2 C. Sommerer,3 I. Aliart,1 O. Rissling,2 B. Bardaji,4 M. Matz,2 M. Zeier,3 I. Silva,4 L. Guirado,4 M. Brunet.1
- 5:30pm-7:30pm
Urine-Derived Cell Lines as a Novel Tool for Monitoring Allo-Reactivity in Kidney Transplant Patients.
C. Thieme,1 B. Weist,1 M. Schmück,1 P. Reinke,1 N. Babel.1,2
« View all sessions from the 2016 American Transplant Congress